Articles
Volume 14 Supplement 2
6th European Symposium: Steps Forward in Pompe Disease
Meeting abstracts
Proceedings of the 6th European Symposium: Steps Forward in Pompe Disease
Berlin, Germany
23-24 November 2012
The symposium and publication of these proceedings were funded by Genzyme Europe BV, Naarden, The Netherlands.
|
Oral presentation
Autophagy: the pathogenic agent in muscle damage Nina Raben BMC Musculoskeletal Disorders 2013, 14(Suppl 2):O1 (29 May 2013) |
|
Oral presentation
Advances in imaging for the diagnosis and disease monitoring of Pompe disease Robert-Yves Carlier BMC Musculoskeletal Disorders 2013, 14(Suppl 2):O2 (29 May 2013) |
|
Oral presentation
Genotype-phenotype: correlations and emerging spectrum Arnold Reuser BMC Musculoskeletal Disorders 2013, 14(Suppl 2):O3 (29 May 2013) |
|
Oral presentation
Diagnostic algorithm and case conundrums: patients presenting with proximal muscle weakness Tiziana Mongini BMC Musculoskeletal Disorders 2013, 14(Suppl 2):O4 (29 May 2013) |
|
Oral presentation
Limitations of muscle biopsy in Pompe disease John Vissing BMC Musculoskeletal Disorders 2013, 14(Suppl 2):O5 (29 May 2013) |
|
Oral presentation
Molecular diagnosis and next generation gene sequencing in neuromuscular clinical practice Silvère van der Maarel BMC Musculoskeletal Disorders 2013, 14(Suppl 2):O6 (29 May 2013) |
|
Oral presentation
Arnold Reuser BMC Musculoskeletal Disorders 2013, 14(Suppl 2):O7 (29 May 2013) |
|
Oral presentation
Stephanie Austin, Priya Kishnani BMC Musculoskeletal Disorders 2013, 14(Suppl 2):O8 (29 May 2013) |
|
Oral presentation
Alglucosidase alfa: 5 years of experience in late-onset Pompe disease Benedikt Schoser BMC Musculoskeletal Disorders 2013, 14(Suppl 2):O9 (29 May 2013) |
|
Oral presentation
Rationale for adjuvant measures in musculoskeletal diseases Ulf Gast BMC Musculoskeletal Disorders 2013, 14(Suppl 2):O10 (29 May 2013) |
|
Oral presentation
Ursula Plöckinger BMC Musculoskeletal Disorders 2013, 14(Suppl 2):O11 (29 May 2013) |
|
Oral presentation
Standards of care in neuromuscular fields Volker Straub BMC Musculoskeletal Disorders 2013, 14(Suppl 2):O12 (29 May 2013) |
|
Poster presentation
Angela Genge BMC Musculoskeletal Disorders 2013, 14(Suppl 2):P1 (29 May 2013) |
|
Poster presentation
Gabriella Horvath, Sandra Sirrs, Sylvia Stockler, Ramona Salvarinova-Zivkovic, Hilary Vallance, Paula Waters BMC Musculoskeletal Disorders 2013, 14(Suppl 2):P2 (29 May 2013) |
|
Poster presentation
Spectrum of Pompe disease in childhood – The Toronto experience J Raiman, G Bendiak, S Hewson, M Mecija, I Narang, M Saunders BMC Musculoskeletal Disorders 2013, 14(Suppl 2):P3 (29 May 2013) |
|
Poster presentation
Pompe practice survey of Canadian (Ontario) rheumatologists Carter Thorne, Mark Tarnopolsky BMC Musculoskeletal Disorders 2013, 14(Suppl 2):P4 (29 May 2013) |
|
Poster presentation
M Hilz, U Hoppe, S Moeller, J Köhn BMC Musculoskeletal Disorders 2013, 14(Suppl 2):P5 (29 May 2013) |
|
Poster presentation
Cytokines in treated and untreated Pompe patients N Karabul, S Gökce, M Kirchner, W Mannhardt, E Mengel BMC Musculoskeletal Disorders 2013, 14(Suppl 2):P6 (29 May 2013) |
|
Poster presentation
Pompe disease: the role of MRI C Pérez Fernández, L Bosanska, U Plöckinger, A Pöllinger BMC Musculoskeletal Disorders 2013, 14(Suppl 2):P7 (29 May 2013) |
|
Poster presentation
N Tiling, L Bosanska, G Gossing, H Krieg, A Krebs, S Rosseau, H Schütte, K Irlbacher, U Plöckinger BMC Musculoskeletal Disorders 2013, 14(Suppl 2):P8 (29 May 2013) |
